Skip to content
CompanySight
Company No. SC319460 · Incorporated 26 Mar 2007

Sartorius Stedim Biooutsource Limited

Registered name: SARTORIUS STEDIM BIOOUTSOURCE LIMITED

Part of Sartorius Stedim Biotech S.A group

Sartorius Stedim Biooutsource Limited made £11.3m revenue and a £4.9m loss in the year to 31 Dec 2023. read from filing text

Sartorius Stedim Biooutsource Limited’s revenue fell 3% to £11.3m in the year to 31 Dec 2023, with a loss of £4.9m and 145 employees. The company is classified under “other professional, scientific and technical activities” and is based in Glasgow; we hold 2 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 74909Other professional, scientific and technical activities n.e.c.
Status
Active
Location
Glasgow, Scotland
Age
19 yrs · since 2007
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2023

Key figures

Revenue
£11.3m
Growth ▼3.2%
Profit
−£4.9m
Growth —
Profit margin
−43.7%
Gross 0.4%
Employees
145
Change ▼13.2%
Profit / employee
−£34.1k
Revenue/employee £78k
Profitable streak
0yrs
Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Dec 202231 Dec 2023
DisclosureFull P&Lread from filing textFull P&Lread from filing text
Profit & loss
Revenue (turnover)£11.7m£11.3m
Cost of sales£9.9m£11.3m
Gross profit£1.7m£45.7k
Operating profit−£4.1m−£4.1m
Profit before tax−£4.4m−£4.9m
Profit (best available)−£4.4m−£4.9m
Staff costs£7.6m£7.1m
Employees (average)167145
Ratios
Profit margin−37.9%−43.7%
Gross margin15%0.4%
Revenue per employee£70k£78k
Profit per employee−£26.5k−£34.1k
Growth (year on year)
Revenue growth—▼3.2%
Headcount growth—▼13.2%
Balance sheet — indirect signals, not revenue
Cash at bank£0£544
Net assets−£4.2m−£8.2m
SourceFullAccounts · bulk data Sep 2024FullAccounts · bulk data Sep 2024
Derived from the latest filing

How the business works

Profit margin
−43.7%
Profit ÷ revenue.
Gross margin
0.4%
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£78k
Revenue ÷ average employees.
Profit per employee
−£34.1k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
—
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
—
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
—
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now −£8.2m
Cash at bank
—
Now £544
Headcount
▼13%
Now 145
Deferred income
—
Now —
Fixed assets
—
Now —
Corporate ownership

Group structure

Ownership chain

  1. Sartorius Stedim Biotech S.A (registered outside the UK register)ultimate parent75–100%
  2. Sartorius Stedim Biooutsource Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Latest figures from FullAccounts for the year to 31 Dec 2023 (profit −£4.9m), from the Companies House accounts bulk data published Sep 2024. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.